01
Growth Hormone Deficiency
Growth hormone deficiency (GHD) is a condition caused by the inadequate secretion of growth hormone (GH) from the anterior pituitary gland.
02
Hypoparathyroidism
Hypoparathyroidism (HP) is a disease characterized by absence or inappropriately low concentrations of circulating parathyroid hormone (PTH), leading to hypocalcaemia, hyperphosphataemia and elevated fractional excretion of calcium in the urine.
03
Achondroplasia
Achondroplasia (ACH) is an autosomal dominant disorder associated with the most common form of dwarfism.
News
More
- 07
- Nov
- 2022
FDA Accepts for Priority Review Ascendis Pharma’s NDA for TransCon™ PTH in Adult Patients with Hypoparathyroidism
- 13
- Jan
- 2022
Ascendis Pharma A/S Receives European Approval for TransCon™ hGH for Pediatric Growth Hormone Deficiency
- 13
- Mar
- 2022
Ascendis Pharma A/S Announces Phase 3 PaTHway Trial of TransCon™ PTH in Adults with Hypoparathyroidism Met Primary and All Key Secondary Endpoints
This website may be linked to websites provided by other organizations, but these websites are not controlled by our company. Our company will not make any guarantee or be liable for any responsibility for the content displayed by these websites.
This website may be linked to websites provided by other organizations, but these websites are not controlled by our company. Our company will not make any guarantee or be liable for any responsibility for the content displayed by these websites.
This website may be linked to websites provided by other organizations, but these websites are not controlled by our company. Our company will not make any guarantee or be liable for any responsibility for the content displayed by these websites.